Literature DB >> 22832288

High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis.

Sumawadee Patiwetwitoon1, Suparaporn Wangkaew, Juntima Euathrongchit, Nuntana Kasitanon, Worawit Louthrenoo.   

Abstract

OBJECTIVE: This study aimed to compare the high-resolution computed tomographic (HRCT) findings between patients with diffuse cutaneous systemic sclerosis (DcSSc) and limited cutaneous systemic sclerosis (LcSSc) as well as to correlate the HRCT scores and the other variables.
METHODS: The medical records of all patients with SSc who presented at the Rheumatology Clinic, Chiang Mai University Hospital, from March 2005 to 2010 and underwent HRCT of the chest for the presence of interstitial lung disease were retrospectively reviewed. The extent of ground glass, lung fibrosis, and honeycombing was scored. All scores were aggregated to produce a total CT perfusion score. The widest coronal esophageal diameter (WED), the maximum diameter of the main pulmonary artery (MPAD), and ascending aortic diameter (AD) were measured. The ratio of MPAD to AD (MPAD/AD) was calculated.
RESULTS: Of the 71 patients with SSc, mean (SD) age and disease duration were 54.8 (11.8) and 3.9 (4.2) years, respectively. Of them, 69.0% were female and 67.6% were classified as having DcSSc. There were no significant differences between patients with DcSSc and LcSSc with respect to age, disease duration, New York Heart Association Functional Classification, the calculated HRCT scores, WED, and MPAD. The lung fibrosis and total CT perfusion score correlated inversely with the SpO2 (r = -0.47, P < 0.01). The honeycombing correlated positively with the New York Heart Association Functional Classification and the WED (r = 0.29 and r = 0.32, respectively, P < 0.05).
CONCLUSIONS: The HRCT scores of these patients were comparable in both subtypes of SSc. Careful evaluation of lungs and esophageal involvement should be performed irrespective of SSc subtypes. The calculated HRCT scores may be useful to assess the severity of the interstitial lung disease in SSc.

Entities:  

Mesh:

Year:  2012        PMID: 22832288     DOI: 10.1097/RHU.0b013e318261176f

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  10 in total

1.  Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients.

Authors:  Suparaporn Wangkaew; Juntima Euathrongchit; Pittaporn Wattanawittawas; Nuntana Kasitanon
Journal:  Quant Imaging Med Surg       Date:  2016-08

2.  Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Paolo Fraticelli; Armando Gabrielli; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2018-04-23       Impact factor: 3.469

3.  Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.

Authors:  Carrie Richardson; Rishi Agrawal; Jungwha Lee; Orit Almagor; Ryan Nelson; John Varga; Michael J Cuttica; Jane D Amico Dematte; Rowland W Chang; Monique E Hinchcliff
Journal:  Semin Arthritis Rheum       Date:  2016-02-26       Impact factor: 5.532

4.  Comment on "Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study".

Authors:  Aileen Hoffmann; Jungwha Lee; Madeleine Ma; Rishi Agrawal; Rowland W Chang; Carrie Richardson; Monique Hinchcliff; Kimberly Showalter
Journal:  Semin Arthritis Rheum       Date:  2016-05-06       Impact factor: 5.532

Review 5.  GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.

Authors:  Marie-Pier Tétreault; Peter Kahrilas
Journal:  Curr Rheumatol Rep       Date:  2019-07-03       Impact factor: 4.592

6.  Esophageal Dilatation as a Predictor of Systemic Sclerosis in Patients with Interstitial Lung Disease.

Authors:  Ana Filipa Santos Duarte de Figueiredo; João Felício Costa; António P Matos; Miguel Ramalho
Journal:  Turk Thorac J       Date:  2021-05

7.  Comparison of clinical and serological parameters in female and male patients with systemic sclerosis.

Authors:  Ewa Wielosz; Maria Majdan; Magdalena Dryglewska; Dorota Suszek
Journal:  Reumatologia       Date:  2016-02-11

8.  Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosis.

Authors:  Marialuisa Bocchino; Dario Bruzzese; Michele D'Alto; Paola Argiento; Alessia Borgia; Annalisa Capaccio; Emanuele Romeo; Barbara Russo; Alessandro Sanduzzi; Tullio Valente; Nicola Sverzellati; Gaetano Rea; Serena Vettori
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

Review 9.  Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.

Authors:  Dinesh Khanna; Oliver Distler; Vincent Cottin; Kevin K Brown; Lorinda Chung; Jonathan G Goldin; Eric L Matteson; Ella A Kazerooni; Simon Lf Walsh; Michael McNitt-Gray; Toby M Maher
Journal:  J Scleroderma Relat Disord       Date:  2022-01-03

10.  Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability.

Authors:  Fausto Salaffi; Marina Carotti; Eleonora Di Donato; Marco Di Carlo; Luca Ceccarelli; Gianmarco Giuseppetti
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.